News
New animal research being presented at the European Congress on Obesity (ECO25) in Malaga, Spain (11–14 May), reveals ...
Donald Trump says he spoke with his friend after he used a story about him buying the 'fat drug shot' overseas at a ...
expert reaction to systematic review and meta- analysis on GLP-1 receptor agonists and mental health
A systematic review published in JAMA Psychiatry looks at weight loss drugs (GLP-1 receptor agonists) and mental health. Prof Stella Chan, Charlie Waller Chair in Evidence-based Psychological ...
Want an oral GLP-1 drug? This Peninsula company just landed a big deal to do it. See how the deal is also a potentially ...
Point32Health will dramatically change how and when it pays for Zepbound — the insurer’s preferred GLP-1 weight-loss drug— ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...
According to a recent study, glucagon-like peptide-1 receptor agonists are associated with a reduction in alcohol intake.
Weekly jabs might not sound glamorous, but Mounjaro and Ozempic are making headlines for more than just managing blood sugar.
Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical ...
Recent research shows combining weight loss with blood sugar control is even more effective for reducing health risks ...
Q1 2025 Earnings Call Transcript May 13, 2025Fractyl Health, Inc. Common Stock reports earnings inline with expectations.
The strategy of rewiring the brain's stress response is rooted in two pieces of scientific literature. One is biochemical.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results